leadf
logo-loader
viewTilray Inc

Tilray shares finish lower after downgrade by Northland Capital Markets

The downgrade came as Tilray secured another supply agreement, ahead of Canada’s legalization of recreational cannabis next month

Company executives at the Tilray Inc debut on Nasdaq in New York
The analyst said that with the recent 'massive move' in the stock, the risk/reward was far more 'balanced at this time'

Shares of Tilray Inc (NASDAQ:TLRY) finished lower on Friday, still feeling the sting after Northland Capital Markets analyst Mike Grondahl downgraded the marijuana company's stock to Market Perform from Outperform.

The stock's valuation was "complex," according to MarketWatch. The analyst added that "one needs to fully appreciate the pendulum swinging toward medicinal and recreational use of cannabis globally."

After recovering in the regular session, the stock closed 2.76% lower at US$77.89 in New York, despite having announced a new cannabis supply deal with Namaste Technologies (CVE:N, OTCMKTS:NXTTF).

READ: Tilray Inc to supply cannabis products to Prince Edward Island

Grondahl said there was still a lot to like about Tilray and he is confident it will be a big player in the cannabis market, and specifically, in the Canadian recreational market, once it launches on October 17.

Among the positives he cited were Tilray's partnership to develop medical products with Sandoz Canada, a division of Novartis AG (NYSE:NVS).

"We have highlighted many positive attributes for Tilray Including Privateer Holdings and Leafly, its partnership with Novartis/Sandoz and distribution deals with Shoppers Drug Mart, Pharmasave and others in the pharmacy space and 7 Canadian provinces," Grondahl wrote.

"However, with the recent (massive) move in the stock, we believe the risk/reward is far more balanced at this time."

According to MarketWatch, the analyst withdrew his stock price target of $60, which was based on expected 2021 revenues of US$492mln.

Still, Tilray, which went public in July, has turned in the best performance of any IPO on a US exchange so far this year, Bloomberg reported on Wednesday.

Shares of Tilray which closed 10.8% down to US$80.10 on Wednesday.

Contact Uttara Choudhury at [email protected]

Follow her on Twitter@UttaraProactive

--Updates shares price, adds Namaste deal--

Quick facts: Tilray Inc

Price: 6.26 USD

NASDAQ:TLRY
Market: NASDAQ
Market Cap: $852.7 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Lotus Resources reveals highlights on scoping study at its Kayelekera...

Lotus Resources Ltd (ASX:LOT) Managing Director Eduard Smirnov tells Proactive the group's Kayelekera Uranium Project can be among first uranium projects to begin production to meet the impending uranium supply shortfall. Smirnov says according to the study, the project will have a long mine...

1 hour, 37 minutes ago

2 min read